EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome

Qiang Chen iD, Yike Li, Xu Chen, Haoming He, Yingying Xie, Yonghui Xu, Yue Cai, Tao Ye, Yanxiang Gao, Shiqiang Xiong, Lin Cai, Jingang Zheng iD

Reviews in Cardiovascular Medicine · 2025-10-28 · 26 (10)

DOI: 10.31083/rcm39246 ↗

At a glance

Journal article in Reviews in Cardiovascular Medicine, published online on 2025-10-28. Written by Qiang Chen and 11 co-authors. Institution: China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences, Peking Union Medical College, 100029 B…. Cited 1 times so far (Crossref); 31 references. The full text is freely available (open access, CC BY 4.0). Funded by: National High Level Hospital Clinical Research Funding, Beijing Research Ward Construction Clinical Research Project, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

The 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation, which incorporates both creatinine and cystatin C, provides enhanced estimation of glomerular filtration rate (eGFR) compared to creatinine-only equations. This study aimed to explore the incremental prognostic value of eGFR estimates in patients with acute coronary syndrome (ACS).

Method

This retrospective analysis evaluated 1400 ACS patients undergoing a percutaneous coronary intervention (PCI). The primary endpoint was defined as major adverse cardiovascular events (MACEs), a composite of all-cause death and nonfatal myocardial infarction (MI). The eGFR values were calculated using three equations: one based solely on serum creatinine (eGFRcr), another based only on cystatin C (eGFRcys), and a combined equation using both creatinine and cystatin C (eGFRcys-cr). Cox regression and the Kaplan–Meier analyses were employed to identify predictors of MACEs. The incremental prognostic value of the three eGFR equations on ACS outcomes was individually assessed.

Results

Over a median follow-up of 31.03 (27.34, 35.06) months, 135 (9.6%) patients experienced MACEs, including 99 (7.1%) deaths and 41 (2.9%) MIs. Lower eGFR values correlated with higher MACEs and the risk of death. Incorporating eGFRcys or eGFRcys-cr into the established risk model improved the predictive accuracy for MACEs. When compared to eGFRcr, eGFRcys-cr demonstrated greater capacity to reclassify the risk for MACEs (category-free continuous net reclassification improvement (cNRI)>0: 0.205 (0.011–0.397); p = 0.03; integrated discrimination improvement (IDI): 0.010 (0.002–0.019); p = 0.01), whereas eGFRcys did not demonstrate a similar effect.

Conclusion

The eGFR based on the 2021 CKD-EPI equation using both creatinine and cystatin C significantly improves risk prediction and reclassification in ACS patients compared with a creatinine-based equation.

Subjects

Author keywords

acute coronary syndromecystatin Cestimating glomerular filtration raterisk stratification

Authors and institutions

  • China-Japan Friendship Hospital (Institute of Clinical Medical Sciences), Chinese Academy of Medical Sciences, Peking Union Medical College, 100029 Beijing, China.
  • Department of Cardiology, China-Japan Friendship Hospital, 100029 Beijing, China.
  • Department of Cardiology, The Third People's Hospital of Chengdu, Affiliated Hospital of Southwest Jiaotong University, 610031 Chengdu, Sichuan, China.

ORCID profiles: Qiang Chen, Jingang Zheng

Funding

  • National High Level Hospital Clinical Research Funding
  • Beijing Research Ward Construction Clinical Research Project
  • National Natural Science Foundation of China
  • Capital's Founds for Health Improvement and Research
  • Chinese Society of Cardiology's Foundation
  • Chengdu High-level Key Clinical Specialty Construction Project

Cite

APA

Chen, Q., Li, Y., Chen, X., He, H., Xie, Y., Xu, Y., Cai, Y., Ye, T., Gao, Y., Xiong, S., Cai, L., & Zheng, J. (2025). Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome. Reviews in Cardiovascular Medicine, 26(10). https://doi.org/10.31083/rcm39246

Vancouver

Chen Q, Li Y, Chen X, He H, Xie Y, Xu Y, et al. Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome. Reviews in Cardiovascular Medicine. 2025;26(10). doi:10.31083/rcm39246

BibTeX
@article{Chen2025,
  author = {Chen, Qiang and Li, Yike and Chen, Xu and He, Haoming and Xie, Yingying and Xu, Yonghui and Cai, Yue and Ye, Tao and Gao, Yanxiang and Xiong, Shiqiang and Cai, Lin and Zheng, Jingang},
  title = {Incremental Prognostic Value of Cystatin C-Based Estimated Glomerular Filtration Rate in Patients With Acute Coronary Syndrome},
  journal = {Reviews in Cardiovascular Medicine},
  year = {2025},
  volume = {26},
  number = {10},
  doi = {10.31083/rcm39246}
}
Start for free →